Meta-analysis measures the effect of etoricoxib on pain and recovery after third molar surgery, indicating potential benefits.
Background: Though postoperative acute pain following third molar extraction impairs patient satisfaction and increases healthcare costs, evidence regarding the efficacy of the highly selective cyclooxygenase-2 (COX-2) inhibitor etoricoxib for preemptive analgesia in this setting remains unclear. Purpose:The purpose of this study was to measure the association of etoricoxib preemptive analgesia on pain and functional recovery after third molar surgery.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: